Loring Wolcott & Coolidge Fiduciary Advisors’s Organon & Co OGN Stock Holding History
Bought
Maintained
Sold
Other funds holding OGN
PMG
AAM
Loring Wolcott & Coolidge Fiduciary Advisors's OGN Position: Q2 2026 in Review
Loring Wolcott & Coolidge Fiduciary Advisors reduced its Organon & Co (OGN) stake by 61% in Q2 2026, selling an estimated $5.08K and leaving 268 shares worth $3.63K. The position accounts for ﹤0.01% of the portfolio, ranked #550.
Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in OGN in Q2 2021 and has held it in 21 quarters since. The position peaked at $553K in Q2 2021. 438 funds tracked by Wall St. Rank hold OGN as of Q2 2026.
- Loring Wolcott & Coolidge Fiduciary Advisors held 268 shares of Organon & Co worth $3.63K as of Q2 2026.
- Loring Wolcott & Coolidge Fiduciary Advisors sold 425 Organon & Co shares in Q2 2026, an estimated $5.08K.
- Organon & Co made up ﹤0.01% of Loring Wolcott & Coolidge Fiduciary Advisors's portfolio in Q2 2026, its #550 holding.
- Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in Organon & Co in Q2 2021 and has held it in 21 quarters since.
- Loring Wolcott & Coolidge Fiduciary Advisors's Organon & Co position peaked at $553K in Q2 2021.
- 438 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.
Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.